(株)キャンバスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4575/E23487 | CanBas Co., Ltd. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/02/19 | 日証協 | 344,200株 | +12.3% | 46,600株 | +15.35% | 285,382株 | +5.82% | 10,500株 | -31.37% |
2016/02/12 | 日証協 | 306,500株 | -2.94% | 40,400株 | +1342.86% | 269,682株 | -0.81% | 15,300株 | +565.22% |
2016/02/05 | 日証協 | 315,800株 | +10.73% | 2,800株 | -84.27% | 271,882株 | +21.66% | 2,300株 | -76.29% |
2016/01/29 | 日証協 | 285,200株 | -11.65% | 17,800株 | +535.71% | 223,482株 | -18.91% | 9,700株 | +125.58% |
2016/01/22 | 日証協 | 322,800株 | -3.38% | 2,800株 | -62.67% | 275,582株 | -1.01% | 4,300株 | -6.52% |
2016/01/15 | 日証協 | 334,100株 | -0.18% | 7,500株 | -11.76% | 278,382株 | +0.43% | 4,600株 | +6.98% |
2016/01/08 | 日証協 | 334,700株 | -5.48% | 8,500株 | -73.1% | 277,182株 | +19.13% | 4,300株 | -85.86% |
2015/12/30 | 日証協 | 354,100株 | +36.14% | 31,600株 | -71.32% | 232,681株 | +6.16% | 30,401株 | -57.42% |
2015/12/25 | 日証協 | 260,100株 | -1.51% | 110,200株 | +459.39% | 219,181株 | -3.86% | 71,400株 | +643.75% |
2015/12/18 | 日証協 | 264,100株 | -1.75% | 19,700株 | +515.62% | 227,982株 | -2.85% | 9,600株 | -30.94% |
2015/12/11 | 日証協 | 268,800株 | -1.39% | 3,200株 | -84% | 234,682株 | +2.27% | 13,900株 | +286.11% |
2015/12/04 | 日証協 | 272,600株 | -4.72% | 20,000株 | +104.08% | 229,482株 | -2.34% | 3,600株 | +2.86% |
2015/11/27 | 日証協 | 286,100株 | +0.95% | 9,800株 | -76.83% | 234,982株 | +0.51% | 3,500株 | -72.44% |
2015/11/20 | 日証協 | 283,400株 | +10.27% | 42,300株 | +88% | 233,782株 | +6.47% | 12,700株 | +29.59% |
2015/11/13 | 日証協 | 257,000株 | -2.02% | 22,500株 | -60.39% | 219,582株 | +0.32% | 9,800株 | -63.3% |
2015/11/06 | 日証協 | 262,300株 | -0.76% | 56,800株 | +361.79% | 218,882株 | -1.35% | 26,700株 | +214.12% |
2015/10/30 | 日証協 | 264,300株 | +1.23% | 12,300株 | +36.67% | 221,882株 | +1.65% | 8,500株 | +117.95% |
2015/10/23 | 日証協 | 261,100株 | -8.48% | 9,000株 | +4.65% | 218,282株 | -3.71% | 3,900株 | -58.95% |
2015/10/16 | 日証協 | 285,300株 | +1.67% | 8,600株 | -7.53% | 226,682株 | +1.3% | 9,500株 | -16.67% |
※株式分割は考慮していませんのでご注意ください。
Page Top